PharmGKB summary: very important pharmacogene information for RYR1

Pharmacogenet Genomics. 2016 Mar;26(3):138-44. doi: 10.1097/FPC.0000000000000198.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Genetic Predisposition to Disease
  • Genetic Variation
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Malignant Hyperthermia / epidemiology
  • Malignant Hyperthermia / genetics*
  • Muscle, Skeletal / metabolism*
  • Muscular Diseases / chemically induced
  • Muscular Diseases / genetics
  • Pharmacogenetics
  • Ryanodine Receptor Calcium Release Channel / genetics*
  • Ryanodine Receptor Calcium Release Channel / metabolism

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Ryanodine Receptor Calcium Release Channel